KLAQW $0.00 0%
3839.HK $1.66 -0.5988%
PRFP.L $1 182.12 0.3324%
WVFC $12.40 0%
0IPB.L $39.39 -0.2785%
ANAT $188.99 0%
IVOL $23.42 -0.4675%
MLPAP.PA $3.26 0%
CLAYW $0.04 20.8459%
LMPX $1.40 0%
FUL $64.90 -1.3977%
APLT $1.57 -4.8485%
RENE.L $7.75 0%
NIM $9.05 -0.1169%
ALCOR.PA $24.40 0%
AMYT.L $143.00 0%
NMI $9.22 0.1086%
BAHI3.SA $9.77 0%
VBOCW $0.05 1.6227%
6080.HK $0.08 0%
TMG.L $50.70 0.3921%
0QIH.L $0.09 0%
1575.HK $0.17 0%
6639.HK $9.86 -4.4574%
ALVAL.PA $3.72 0.5405%
0P000185T5.L $17 175.70 0.2703%
EPM $7.01 3.0882%
TTEK $145.07 -1.3331%
VOO $375.98 -0.7078%
ASNS $3.56 0%
FCRZ $25.27 0%
CMIG3.SA $19.75 -0.9529%
BOEI.BR $208.00 0%
ZJZZT $14.25 0%
PSB $187.44 0%
WQGA $10.28 0%
CUZ $19.95 -2.2304%
BRAP4.SA $21.79 -1.3134%
DQ $42.93 -0.7399%
2608.HK $0.37 0%
SUWS.L $7.53 -0.0498%
1142.HK $0.44 0%
1175.HK $0.06 0%
XOMAP $23.49 0.5996%
ATEB.BR $38.90 0%
MERC3.SA $15.11 0%
0U8N.L $143.42 7.5112%
FSKY.L $2 171.75 -0.2526%
DNAY $1.30 -26.5537%
VUAA.L $76.81 -0.0911%
0082.HK $0.18 -2.1505%
RMMC.L $150.00 0%
NHF $14.66 0%
ALCJ.PA $3.33 0.1504%
SBAC $233.73 0.2896%
AFS.L $364.00 0%
0QQR.L $88.70 1.7868%
MFA $10.16 -1.5988%
IME.L $17.75 0%
FSG.L $411.00 0.2439%
VERI $3.85 -3.99%
VAL.L $10.00 0%
GIGGW $1.26 0%
INFU $9.00 0.3512%
DSM.L $65.25 0%
CFVI $12.04 0%
0Y0Y.L $274.17 1.2915%
PEI-PB $3.40 112.5%
IBT.L $678.00 0.5935%
CRPU.SI $0.75 0%
BPRN $24.14 -1.4694%
GSMG $0.65 -3.4739%
PRLH $10.49 0.0954%
HUDI $5.20 -7.6377%
LMRKP $25.47 0%
MUFG $6.40 -0.4666%
2007.HK $1.88 -3.0928%
PAY.L $427.50 -0.4657%
Z59.SI $0.10 -1%
EEH $32.45 0%
LTBR $4.15 5.9056%
IQG.L $258.00 0.3891%
1786.HK $0.84 0%
ALVOW $1.35 12.5%
EOD $4.18 -0.45%
OVB $20.88 -0.5932%
BWAQW $0.05 -24.4713%
0777.HK $14.88 -1.457%
IBDX $24.90 -0.42%
0694.HK $5.78 -2.3649%
FHN-PE $18.04 -0.0554%
MLMIB.PA $0.28 0%
0P0001K1DP.L $12 607.90 0.3638%
ORR.L $0.23 9.7561%
MOTS $0.75 -6.25%
CLTL $105.62 -0.0095%
VAN.BR $33.50 0.9036%
0M1U.L $72.27 0%
BTZ $10.31 -0.6852%
2198.HK $1.66 0%
Eng
Логотип
Eng
Лого

Scancell Holdings plc SCLP.L

$15.75

-$0.25 (-1.56%)
На 18:02, 12 мая 2023

Ключевые показатели

  • Marketcap

    126852466.00000000

  • week52high

    29.40

  • week52low

    10.75

  • Revenue

    0

  • P/E TTM

    -6020

  • Beta

    0.59694600

  • EPS

    -0.01000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    25 янв 2023 г. в 10:59

Описание компании

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек